Nanohealth Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance Analyst monitors the safety of medicines after they reach the market by collecting, assessing, and reporting adverse events. Day to day, you screen case reports, enter data into safety databases, code events and drugs using MedDRA and WHO Drug dictionaries, assess causality and expectedness, and help submit expedited reports to regulators within strict timelines. In a fast-growing company, you may also support literature screening, signal detection, and writing aggregate reports.

Role and technical knowledge

1. 1

   What is the difference between an adverse event and an adverse drug reaction, and why does it matter in pharmacovigilance?

   Explain that an adverse event is any untoward medical occurrence after exposure, while an ADR implies a causal relationship. Mention that the distinction affects reporting and causality assessment.

2. 2

   What are the four minimum criteria for a valid ICSR, and which one is most often missing in practice?

   List identifiable patient, identifiable reporter, suspect product, and adverse event. Note that a specific adverse event or reporter details are commonly incomplete, and describe how you would follow up.

3. 3

   How do you decide if a case is serious, and what are the regulatory reporting timelines for serious unexpected cases?

   Cover seriousness criteria such as death, life-threatening, hospitalization, disability, congenital anomaly, or medically important event. Mention 15 calendar days for expedited reporting to regulators like CDSCO or FDA.

4. 4

   What is MedDRA used for, and what is the difference between an LLT and a PT?

   MedDRA codes adverse events. LLT is the lowest level term, most granular, while PT is the preferred term, a single medical concept used for analysis. Give a simple example.

Practical scenarios

1. 5

   You receive a call from a patient who reports a rash after taking a new antibiotic. Walk me through how you would process this as a case.

   Show steps: collect patient and reporter details, suspect drug, event description, onset and outcome, check seriousness, enter into safety database, code with MedDRA, assess causality, and decide on reporting.

2. 6

   A case report is missing the patient's age and the start date of the suspect drug. What do you do?

   Explain that you would document what is available, mark missing fields clearly, and initiate follow-up with the reporter. Note that you should not invent data and should record the follow-up attempts.

3. 7

   How would you handle a case where the reporter is a lawyer asking for compensation rather than a healthcare professional?

   Focus on treating it as a valid report if it meets minimum criteria, documenting the source, and not giving legal or compensation advice. Mention escalating to your manager or legal team as per company policy.

4. 8

   You notice a typo in a case you already submitted. What is your course of action?

   Describe correcting the case in the database, documenting the change with a rationale, and assessing whether a follow-up or amended report is needed. Emphasize transparency and audit trail.

Behavioural and situational questions

1. 9

   Tell me about a time you had to follow a detailed process or checklist without making errors.

   Use a STAR example from an internship, lab work, or academic project. Highlight your attention to detail, double-checking, and how you handled any mistake.

2. 10

   Pharmacovigilance involves strict deadlines. How do you prioritize when multiple cases are pending?

   Explain triaging by seriousness and reporting timeline, using tools like to-do lists or trackers, and communicating early if you need help. Mention not compromising quality for speed.

3. 11

   Describe a time you had to explain a complex medical or scientific concept to someone without a science background.

   Show clarity, empathy, and use of simple language. Connect it to how you would communicate with patients or reporters while collecting adverse event information.

4. 12

   Why do you want to work in pharmacovigilance, and what do you know about the role in a growing company?

   Express genuine interest in patient safety and drug monitoring. Mention willingness to learn new databases and guidelines, and comfort with a fast-paced, process-driven environment.

HR and company fit

1. 13

   What do you understand about the work culture in a smaller or fast-growing healthcare company?

   Talk about flexibility, broader responsibilities, direct impact on patient safety, and the need to adapt as processes evolve. Avoid assuming a rigid corporate structure.

2. 14

   How do you handle confidential patient information, and what does data privacy mean to you?

   Mention not sharing patient details outside authorized systems, using secure channels, and following company SOPs and regulations like HIPAA or India's DPDP Act.

3. 15

   Where do you see yourself in two to three years in pharmacovigilance?

   Show a realistic growth path, such as moving from case processing to signal detection, aggregate reporting, or quality review, while staying grounded in current learning.

4. 16

   Do you have any questions for us about the role or the team?

   Ask about training on safety databases, typical case volume, mentorship, or how the team handles regulatory inspections. This shows serious interest and preparation.